Methods for reducing the risk of an adverse dronedarone/calcium channel blockers interaction in a patient suffering from atrial fibrillation

Details for Australian Patent Application No. 2010202705 (hide)

Owner Sanofi-Aventis

Inventors Gaud, Christine; Radzik, Davide

Agent A J Park

Pub. Number AU-A-2010202705

Filing date 29 June 2010

Wipo publication date 19 January 2012

International Classifications

A61P 9/06 (2006.01) Drugs for disorders of the cardiovascular system

A61K 31/343 (2006.01) - condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone

Event Publications

15 July 2010 Complete Application Filed

19 January 2012 Application Open to Public Inspection

  Published as AU-A-2010202705

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010202706-Apparatus with flexibly mounted spud carriage

2010202704-Methods For Predicting Warp Of A Wood Product Produced From A Log